Archive » No 01+02/2005

Table of contents:

What Cardiologists do Need to Know about Procalcitonin
Clin. Lab. 2005;51(1-2):1-4.
by Christian Mueller, Mirjam Christ-Crain, Beat Müller
Abstract Buy Fulltext PDF

The Use of B-type Natriuretic Peptide in the Diagnosis of Acute Dyspnoea
Clin. Lab. 2005;51(1-2):5-9.
by Christian Mueller, Kirsten Laule-Kilian, Andreas Christ, Daniel Staub
Abstract Buy Fulltext PDF

Serum Hyaluronic Acid Levels are Elevated in Arthritis Patients, but Normal and Not Associated with Clinical Data in Patients with Fibromyalgia Syndrome
Clin. Lab. 2005;51(1-2):11-19.
by Egon Werle, Hans-Peter Jäkel, Annette Müller, Heinrich Fischer, Walter Fiehn, Wolfgang Eich
Abstract Buy Fulltext PDF

Evolution of the Parathyroid Hormone (PTH) Assay - Importance of Circulating PTH Immunoheterogeneity and of its Regulation
Clin. Lab. 2005;51(1-2):21-29.
by Ping Gao and Pierre D'Amour
Abstract Buy Fulltext PDF

The Abbott Architect c8000: Analytical Performance and Productivity Characteristics of a New Analyzer Applied to General Chemistry Testing
Clin. Lab. 2005;51(1-2):31-41.
by Daniela Pauli, Michael Seyfarth, and Leif Dibbelt
Abstract Buy Fulltext PDF

Clinical Significance of Hematocrit Interference in the Tacrolimus II Microparticle Enzyme Immunoassay: A Tentative Approach
Clin. Lab. 2005;51(1-2):43-45.
by Jesús Hermida, M. Concepcion Fernändez, J. Carlos Tutor
Abstract Buy Fulltext PDF

Letter to the Editor: Sealing Ability of a Glass Ampoule
Clin. Lab. 2005;51(1-2):47.
by Yutaka Tajima
Buy Fulltext PDF

Evaluation of Alkaline Phosphatase Activity Assay for the Reflotron8 System after Substitution of the Comparison Method
Clin. Lab. 2005;51(1-2):49-53.
by Ulrich Hübner, Gerhard Pape, Johannes Lotz, Thomas Bertsch, Manfred Kraft, Jürgen Geisel,and Wolfgang Herrmann
Abstract Buy Fulltext PDF

Rationale for Testing the Cardiovascular Risk for Patients with COX-2 Inhibitors on the Basis of Biomarker NT-proBNP
Clin. Lab. 2005;51(1-2):63-72.
by Evangelos Giannitsis
Abstract Buy Fulltext PDF

Rationale zur Testung des kardiovaskulären Risikos bei Patienten mit COX-2-Hemmern anhand des Biomarkers NT-proBNP
Clin. Lab. 2005;51(1-2):73-83.
by Evangelos Giannitsis
Abstract Buy Fulltext PDF

Official Journal of the:
GERMAN ASSOCIATION OF BLOOD TRANSFUSION SERVICES (StKB)
PROFESSIONAL ASSOCIATION OF SCIENTISTS IN LABORATORY DIAGNOSTICS (BNLD)

Print Mon 6th Feb, 2012